[Pharmacovigilance as new direction of research].
Pharmacovigilance: permanent collection and assessment of the safety data of the drug, in the interest of precise knowledge of the safety profile of the pharmacon; permanent collection of unexpected adverse drug reactions, effects on special patient populations, drug interactions, adverse drug reactions of long-term treatment, adverse drug reactions of long latency. Our study was performed under the tutelage of the Drug Safety Programme in Psychiatry (AMSP), 2004. We review the side effects occuring in the different organ systems; side effects during the use of antidepressive and antipsychotic therapy. We review how the danger of polypharmacy can be avoided by reducing the dose of the current drug; by using therapeutic drug; or just by monitoring therapeutic and adverse effects.
Országos Pszichiátriai és Neurológiai Intézet, Budapest. gasznergabor@yahoo.com
Gábor
G
Gaszner
Zoltán
Z
Makkos
Péter
P
Gaszner
D016907:Adverse Drug Reaction Reporting Systems; D000928:Antidepressive Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D035843:Biomedical Research / Q000639:trends; D004346:Drug Information Services; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D006814:Hungary; D019338:Polypharmacy; D011358:Product Surveillance, Postmarketing; D011619:Psychotropic Drugs / Q000008:administration & dosage / Q000009:adverse effects*
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D011619:Psychotropic Drugs